Urotensin II Modulates renal interstitial fibrosis in rats

被引:0
|
作者
Dan W. [1 ]
Yifei L. [2 ]
Lianyou Y. [3 ]
Hong L. [3 ]
Yundong W. [3 ]
机构
[1] Basic medical college, Beihua University, Jilin City
[2] Jilin Central Hospital, Jilin City
[3] The Hospital of Jilin Chemical Industry Company, Jilin City
关键词
GPR14; Renal interstitial fibrosis; Urotensin II;
D O I
10.4156/jcit.vol6.issue12.45
中图分类号
学科分类号
摘要
Urotensin-II (UII) is a potent vasoactive peptide, playing an important role in the heart, kidneys and central nervous system. In this study, we investigated the effects of urotensin II on renal fibrosis and its mechanism. The renal interstitial fibrosis model were induced by unilateral ureteral obstruction (UUO) in rats, and the rat renal interstitium fibroblasts (NRK-49F) were used for in vitro mechanism study. Results showed that expression of UII and GPR14 was significantly upregulated at both mRNA and protein levels in the UUO group compared with controls; The pathological features with Masson's trichrome-staining included collagen girdle-shaped in the interstitial of kidney which be ligated; U II exerted the stimulative effect on NRK-49F cell proliferation and DNA synthesis when U at concentrations of 10 -9 and 10 -8mol/L, compared with the Sham group (P<0.01); U II promoted the transdifferentiation of NRK-49F cells by stimulate the expression of the α-SMA and increased the accumulation of ECM, TGF-β1 and CTGF. We concluded that The expression of U II and GPR14 in renal tubular interstitium of UUO rats was increased significantly, and U II may play a crucial role in the progression of kidney fibrosis.
引用
收藏
页码:360 / 368
页数:8
相关论文
共 50 条
  • [41] Origin of interstitial fibroblasts in a model of angiotensin II-induced renal fibrosis
    Schlondorff, D
    KIDNEY INTERNATIONAL, 2006, 69 (04) : 647 - 648
  • [42] Urotensin Ⅱ accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol
    Yong-gang ZHANG~(2
    3 The Affiliated Hospital
    Acta Pharmacologica Sinica, 2007, (01) : 36 - 43
  • [43] Urotensin II increases portal pressure and induces hepatic fibrosis
    Kemp, William
    Henry, Krum
    Kompa, Andrew
    Zhiyuan, Jia
    Angus, Peter W.
    Roberts, Stuart K.
    HEPATOLOGY, 2007, 46 (04) : 565A - 565A
  • [44] The Efficiency of a Urotensin II Antagonist in an Experimental Lung Fibrosis Model
    Ahmet Mesut Onat
    Ibrahim Halil Turkbeyler
    Yavuz Pehlivan
    Tuncer Demir
    Davut Sinan Kaplan
    Seyithan Taysi
    Ali Osman Ceribasi
    Ediz Tutar
    Bunyamin Kisacik
    Inflammation, 2012, 35 : 1138 - 1143
  • [45] The Efficiency of a Urotensin II Antagonist in an Experimental Lung Fibrosis Model
    Onat, Ahmet Mesut
    Turkbeyler, Ibrahim Halil
    Pehlivan, Yavuz
    Demir, Tuncer
    Kaplan, Davut Sinan
    Taysi, Seyithan
    Ceribasi, Ali Osman
    Tutar, Ediz
    Kisacik, Bunyamin
    INFLAMMATION, 2012, 35 (03) : 1138 - 1143
  • [46] Renal haemodynamic and tubular actions of urotensin II in the rat
    Abdel-Razik, Alaa E. S.
    Forty, Ellen J.
    Balment, Richard J.
    Ashton, Nick
    JOURNAL OF ENDOCRINOLOGY, 2008, 198 (03) : 617 - 624
  • [47] Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats
    Nishiyama, A
    Seth, DM
    Navar, LG
    HYPERTENSION, 2002, 39 (01) : 129 - 134
  • [48] Urotensin II: Evidence for cardiac, hepatic and renal production
    Charles, CJ
    Rademaker, MT
    Richards, AM
    Yandle, TG
    PEPTIDES, 2005, 26 (11) : 2211 - 2214
  • [49] The role of urotensin II in cardiovascular and renal physiology and diseases
    Zhu, Yi-Chun
    Zhu, Yi-Zhun
    Moore, Philip Keith
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) : 884 - 901
  • [50] Molecular insights into renal interstitial fibrosis
    Eddy, AA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (12): : 2495 - 2508